Detalhe da pesquisa
1.
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914929
2.
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus.
Nat Commun
; 12(1): 3391, 2021 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099646
3.
Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE.
Lupus Sci Med
; 6(1): e000332, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413851
4.
Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus.
Arthritis Rheumatol
; 71(7): 1135-1140, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597768
5.
Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.
JCI Insight
; 3(8)2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669944